-transparent.png){kind=logo}
Copolymer 1 (Cop 1) inhibits experimental allergic encephalomyelitis induced by a variety of myelin proteins, but has been found ineffective so far in inhibiting other experimental autoimmune diseases such as diabetes or arthritis. Here, we report for the first time that Cop I inhibits the development of experimental autoimmune uveoretinitis, induced in mice by interphotoreceptor retinoid-binding protein (IRBP). Pooled data of three experiments showed that treatment with Cop 1, at 0.5 mg/mouse, reduced the disease severity by 53% ( p = 0.0002). Cop 1 treatment also inhibited the proliferation and the production of cytokines by lymph node cells in response to IRBP and moderately reduced the antibody response to this antigen. The possible mechanisms of EAU inhibition by Cop 1 are discussed.
M Zhang, and
C C Chan, and
B Vistica, and
V Hung, and
B Wiggert, and
I Gery
December 2012,
Experimental eye research,
M Zhang, and
C C Chan, and
B Vistica, and
V Hung, and
B Wiggert, and
I Gery
May 2009,
Investigative ophthalmology & visual science,
M Zhang, and
C C Chan, and
B Vistica, and
V Hung, and
B Wiggert, and
I Gery
August 1990,
Immunology today,
M Zhang, and
C C Chan, and
B Vistica, and
V Hung, and
B Wiggert, and
I Gery
January 1987,
Japanese journal of ophthalmology,
M Zhang, and
C C Chan, and
B Vistica, and
V Hung, and
B Wiggert, and
I Gery
December 1996,
Current eye research,
M Zhang, and
C C Chan, and
B Vistica, and
V Hung, and
B Wiggert, and
I Gery
January 2012,
PloS one,
M Zhang, and
C C Chan, and
B Vistica, and
V Hung, and
B Wiggert, and
I Gery
July 1988,
Nippon Ganka Gakkai zasshi,
M Zhang, and
C C Chan, and
B Vistica, and
V Hung, and
B Wiggert, and
I Gery
November 1998,
Experimental eye research,
M Zhang, and
C C Chan, and
B Vistica, and
V Hung, and
B Wiggert, and
I Gery
May 2007,
Journal of immunology (Baltimore, Md. : 1950),
M Zhang, and
C C Chan, and
B Vistica, and
V Hung, and
B Wiggert, and
I Gery
June 1990,
Journal of autoimmunity,
